October 01, 2014 2:58 AM ET

Pharmaceuticals

Company Overview of REN Pharmaceuticals, Inc.

Company Overview

REN Pharmaceuticals, Inc. develops and markets therapeutics for renal and associated cardio-renal diseases. The company offers data and useful reagents, including antibodies and recombinant proteins for studying the biology of renalase. Its products are used in the prevention and treatment of kidney disease and associated comorbid conditions. REN Pharmaceuticals, Inc. was founded in 2006 and is based in South San Francisco, California.

270 East Grand Avenue

South San Francisco, CA 94080

United States

Founded in 2006

Phone:

650-244-9647

Key Executives for REN Pharmaceuticals, Inc.

Chairman
Age: 55
Chief Business Officer
Vice President of Research
Age: 40
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Novartis Vaccines and Diagnostics, Inc. United States
Chartwell Pharmaceuticals LLC United States
Enhance Biotech Inc. United States
TesoRx LLC United States
ARIIX Holdings, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REN Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.